Dr. Nagourney's Blog

Treating an 83-yr-old With Neuroendocrine Cancer: All in Good Measure

A recent editorial entitled "More Proof That Less Chemo is Best in Elderly Colorectal Cancer Patients" (David Kerr, Medscape, January 24, 2019) examined the benefits of Oxaliplatin-based therapy in older patients from a study in The Annals of...

Woman with Both Breast and Pancreatic Cancer: Finding an Achilles Heel

With the rapid rise of cancer, medical oncologists sometimes find themselves treating family members, friends or neighbors. In...

For a 26-year-old Stage 4 Adrenal Cancer: It's Knowing Where (and How) to Look

“When you have eliminated the impossible, whatever remains, however improbable, must be the truth” Sherlock Holmes The Sign of...

Serendipity Saves a Life for a Patient with Advanced Breast Cancer

In early September of 2018, I consulted with a 51-year-old patient with heavily pre-treated, extremely advanced metastatic...

For Some Cancers Are There Immunotherapy Hazards?

A report by French investigators has raised concern regarding the broad application of immunotherapy in lung cancer. Checkpoint...

Cancer, Computers and Genes: A Bad Mix for Patients

Every day, we hear of another breakthrough using gene testing and DNA to identify a new target, new treatment, new combination...

High Cost of Cancer Care To 340B or Not To 340B, That Is The Question?

There are many reasons why medical care costs continue to spiral out of control. Some of these are systemic like an aging...